Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beamocular is a private Swedish medical device and healthcare solutions company focused on radiation oncology and radiology rather than drug development. Founded in 2021 and commencing operations in 2024, the company positions itself as a partner for clinics and industrial customers seeking advanced radiotherapy, dosimetry, quality assurance, and medical imaging solutions. Its website emphasizes pre-purchase consultation, system configuration, IT infrastructure support, and distribution of high-quality devices for the Nordic market and beyond. Beamocular appears to operate as a commercial-stage provider and distributor of radiation therapy and imaging products, with a focus on patient safety, treatment accuracy, and implementation of an ISO 13485-compliant quality management system.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beamocular.